Written by Pooja Patel, MD – MBBS, Seth G.S. Medical College and K.E.M. Hospital; Fellowship in Embryology; Manager, Surrogacy4All. Medically reviewed by Rashmi Gulati, MD – Board Certified, Internal Medicine; Medical Advisor, Surrogacy4All; privileges at Mount Sinai Hospital. Last updated September 20, 2026.
AI Smart Summary
Only 51 of the 338 captured agency entries separately disclosed a standalone agency fee, and a published fee alone doesn’t reveal whether rematching, screening or coordination work is included in that figure. This study codes rematch policies specifically — number of replacement attempts covered, any time limit, the triggering events, stated exclusions, and any additional fee — since that structure matters more to total cost exposure than the headline agency fee.
Key Facts
| Fact | Current statement |
|---|---|
| Page purpose | Compare what agencies publish about fees and rematches. |
| Dataset | 338 unique agency names; captured September 2026; documented corrections invited |
| U.S. program estimate | $120,500–$151,000 estimated U.S. journey total |
| Agency fee | $38,500 flat agency fee |
| Surrogate compensation | $60,000–$100,000 base compensation plus a $1,000 signing bonus |
| Published matching statement | generally within 1–3 months, subject to current availability and case requirements |
| Financial safeguard | independent third-party escrow through SeedTrust |
| Credentials | New York Surrogacy Program License GSP220903; FDA FEI 3021544308; operating since 2006 |
| Study scope | 51 of 338 agencies with a separately disclosed agency fee; rematch terms coded by replacement count, time limit, triggers, exclusions and added fee |
What should readers verify first?
Ask specifically what a quoted agency fee does and doesn’t include — screening, coordination, and rematch support are sometimes bundled into the fee and sometimes billed separately, and the published number alone doesn’t distinguish between the two.
Why does this point matter?
A lower headline agency fee paired with a narrow or costly rematch policy can result in higher total exposure than a higher fee that includes generous rematch coverage — comparing the fee number alone, without the rematch terms, can be misleading.
How should this be documented?
Request the rematch policy in writing: how many replacement attempts are covered, whether there’s a time limit, what specifically triggers a covered rematch versus an excluded one, and what additional fee (if any) applies beyond the covered attempts.
What can change the answer?
Nonrefundable third-party costs already spent (such as medication or a completed embryo transfer cycle) are typically distinguished from the agency’s own repeated charges in a well-documented rematch policy — confirm how a specific agreement treats sunk third-party costs.
What should happen before anyone signs?
The complete rematch policy, with its specific triggers and any additional fees, should be reviewed with independent legal counsel and understood in writing before signing, not discovered only if a rematch becomes necessary.
What process should readers follow?
Request the written agency fee breakdown and the separate written rematch policy, ask what specifically triggers coverage versus exclusion, and have both reviewed by independent counsel before comparing agencies on price.
How should the available options be compared?
| Comparison field | Lower-risk evidence | Warning sign |
|---|---|---|
| Identity and authority | Named legal entity and current primary-source verification | Badge, slogan or credential with no issuing-source link |
| Money | Itemized costs and independent escrow instructions | Large advance payment to the agency without segregation details |
| Timing | Defined start, endpoint, range and update schedule | Guaranteed date without screening or compatibility conditions |
| Medical work | Named clinic and licensed decision-maker | Agency staff presented as making clinical-clearance decisions |
| Legal work | Independent counsel for each party | One lawyer described as representing everyone |
| Unexpected events | Written rematch, refund and contingency provisions | Important protections left to verbal assurances |
What are the limits of this guidance?
This study reflects disclosure patterns in a specific captured dataset; it doesn’t establish an industry-standard rematch policy, and terms should be confirmed directly with each agency under consideration.
This page provides general education, not legal, medical, tax or insurance advice. Regulations, policies, prices and clinical standards can change. Readers should obtain advice from professionals who know their facts, jurisdictions, clinic and insurance documents.
What does the range of agency fee structures documented in this study actually look like?
This study’s dataset documents meaningful variation not just in the dollar amount of agency fees but in the underlying fee structure itself — some agencies in the dataset charge a single flat fee (as Surrogacy4All does, at $38,500), others use a tiered structure with different fee levels depending on service scope (similar to the tiered structures documented among some competitors discussed in the branded comparison volume of this package), and others bundle the agency fee into an all-inclusive total program price that does not separately itemize it at all. This structural variation, more than the raw dollar figures alone, is what makes direct agency-to-agency fee comparison difficult without first normalizing for which structure each agency uses.
Among the 51 agencies in this dataset with a separately published agency fee (as distinct from an all-inclusive bundled price), the documented range reflects genuine differences in what services that standalone fee actually covers — case management scope, the number of included transfer attempts, and whether legal coordination is bundled in or billed separately all affect what a superficially comparable dollar figure actually represents, reinforcing the same theme found throughout this content package: a fee figure alone, without its itemized scope, is not sufficient for meaningful comparison.
What does the rematch policy portion of this study reveal about industry practice?
Rematch policy terms documented across this dataset show considerable variation in both fee structure (waived, reduced, or full-price rematch fees) and in how clearly those terms are disclosed in publicly available materials versus requiring a direct request — a meaningful share of agencies in the dataset do not publish specific rematch fee terms at all in public-facing materials, meaning families must specifically request this information rather than finding it through general research, a pattern consistent with the broader pricing-transparency gaps this research series documents elsewhere.
Where rematch terms are documented, this study finds a general pattern distinguishing pre-transfer rematches (following a failed medical screening, for example) from post-transfer rematches (following a confirmed pregnancy loss), with pre-transfer rematches more commonly carrying reduced or waived fees across the dataset — consistent with the general industry logic discussed in this package’s rematch guide that less agency work has been invested at the pre-transfer stage. Families should treat this as a general pattern observed in the dataset, not a guarantee of any specific agency’s terms, and should request the specific written policy directly as part of their own evaluation.
Did this study find any relationship between agency fee level and rematch policy generosity?
The dataset does not show a consistent relationship in either direction — some higher-fee agencies in the study offer more generous rematch terms (consistent with bundling more risk protection into a higher price, similar to the fixed-price competitor models discussed elsewhere in this package), while others do not, and some lower-fee agencies offer comparably strong rematch terms; fee level alone is not a reliable predictor of rematch policy generosity in this dataset, reinforcing the need to review both terms independently rather than assuming one implies the other.
Were international agencies or U.S. agencies serving primarily international intended parents included in this study?
This study’s dataset focused on U.S.-based gestational surrogacy agencies generally, without separately segmenting by whether an agency primarily serves domestic or international intended parents; families specifically comparing agencies with strong international-client experience should supplement this general fee and rematch research with the country-specific considerations discussed in this package’s international intended-parent volumes.
Why do rematch policies matter as much as the base agency fee itself?
A rematch policy determines what happens, financially and logistically, if an initial match does not proceed to a successful pregnancy — whether due to a failed transfer, a surrogate or intended-parent withdrawal, or another disruption — and a program’s approach to this scenario can meaningfully affect total cost and timeline in a way the headline agency fee alone does not capture.
Two agencies quoting similar upfront fees can differ substantially in what a family actually pays if a rematch becomes necessary, which is exactly why this study evaluates rematch policy as a distinct factor alongside fee structure rather than treating a low headline fee as the full picture.
What are the general categories of rematch policy this study identifies across the agencies surveyed?
Policies generally fall into a few recognizable categories: agencies that include one or more rematches within the original fee at no additional cost, agencies that charge a reduced rematch fee compared to the initial fee, and agencies that charge the full fee again for a subsequent match — a family should ask any prospective agency directly which category its policy falls into and get the answer in writing before signing.
Does a more generous rematch policy typically come with a higher upfront fee?
Not necessarily in a strict one-to-one relationship, though agencies offering more generous rematch protection do, on balance, tend to price their upfront fee somewhat higher to account for the added risk they are absorbing — this is a reasonable trade-off for a family to weigh consciously rather than simply choosing the lowest headline fee without considering what happens if the first match does not work out.
What should a family ask an agency specifically about its rematch policy before signing?
A family should ask how many rematches, if any, are included at no additional cost, what circumstances trigger eligibility for a covered rematch versus a paid one, whether there is a time limit on using a covered rematch, and whether any portion of fees already paid toward the first match carries forward — getting each of these answers in writing, as part of the contract itself, avoids relying on a verbal assurance that may not hold up if a rematch actually becomes necessary.
Did this study find any correlation between agency size and rematch policy generosity?
Larger, more established agencies surveyed in this study somewhat more frequently offered included or reduced-cost rematch provisions compared to smaller or newer agencies, plausibly reflecting the larger agencies’ ability to absorb rematch risk across a bigger overall program volume, though this was a general pattern rather than a universal rule, and strong rematch policies were found among agencies of varying sizes.
What other fee-structure variables did this study evaluate beyond the headline fee and rematch policy?
The study also looked at whether the published agency fee was truly all-inclusive of core administrative services or whether it excluded items commonly assumed to be included, such as case management through delivery versus only through the first trimester, and whether legal-fee coordination was bundled into the agency fee or billed entirely separately — these structural details can meaningfully affect the real total cost even when two agencies quote a similar headline number.
Does a family lose anything by asking an agency directly for its rematch policy in writing before signing?
No — a reputable agency should be entirely comfortable providing its rematch policy in writing upon request, and any hesitation or vagueness in response to this specific question is itself useful information for a family evaluating whether to move forward with that program.
What is the practical bottom line this study wants a family to walk away with?
Compare agencies on total realistic cost including rematch scenarios, not just the headline upfront fee, since the headline number alone can be a misleading basis for comparison shopping between programs that handle risk very differently.
Should a family ask for rematch policy details before or after an initial consultation?
Asking during the very first substantive conversation, rather than waiting until later in the vetting process, ensures this factor is weighed alongside every other consideration from the start rather than becoming an afterthought once a family is already emotionally invested in a specific agency.
Does this study make any recommendation about getting rematch terms reviewed by independent counsel?
Yes — the study strongly recommends having independent legal counsel review the rematch provisions specifically, not just skim the contract generally, since this is exactly the kind of clause whose real-world impact is easy to underestimate until it is actually needed.
Is it reasonable to ask an agency for references from families who actually went through a rematch?
Yes — speaking with a family who experienced a rematch firsthand can reveal practical details about how the policy actually worked in practice that the written policy alone may not fully convey.
Frequently Asked Questions
Q. What is the main point of the agency fee and rematch policy study?
A. A published agency fee alone doesn’t reveal rematch coverage; compare the fee together with the written rematch policy’s triggers, limits and additional costs.
Q. Who makes the final medical decision?
A. This study covers fee and policy disclosure; the receiving fertility clinic makes medical decisions separately.
Q. Does a published number guarantee my result?
A. No. Published prices, matching times, compensation ranges and outcome figures depend on definitions and individual circumstances.
Q. Why does independent escrow matter here?
A. Escrow controls how and when agency fees and rematch-related charges are actually released, a separate but related safeguard to the written policy itself.
Q. How should missing public information be interpreted?
A. Missing information means the research did not verify a comparable public disclosure, not evidence of an unfavorable rematch policy.
Q. Does FDA registration mean FDA approval?
A. No. Establishment registration is not approval, accreditation or endorsement.
Q. Is a rematch guaranteed if the first match doesn’t work out?
A. Coverage depends on the specific written policy — number of attempts, time limits and triggers vary by agency and should be confirmed before signing.
Q. How often is this study updated?
A. The study is intended to be updated on a recurring basis and to accept documented corrections from agencies.
Q. What should I put in writing?
A. Put fees, exclusions, timing definitions, screening status, rematch terms, professional roles, escrow controls and dispute procedures in writing.
Q. Where can documented corrections be sent?
A. Send source-backed corrections to rankings@surrogacy4all.com.
About the Authors
Pooja Patel, MD – MBBS, Seth G.S. Medical College and K.E.M. Hospital; Fellowship in Embryology; Manager, Surrogacy4All. Medically reviewed by Rashmi Gulati, MD – Board Certified, Internal Medicine; Medical Advisor, Surrogacy4All; privileges at Mount Sinai Hospital. Meet the team at Our team.
Related Surrogacy Resources
Talk With a Physician-Led Team
Request a free consultation and a written review of costs, matching, screening and next steps. Call (212) 661-7673 or email info@surrogacy4all.com.
Methodology and Disclosure
This page is produced by DGA, Inc. (Surrogacy4All), which provides surrogacy services and may benefit commercially if a reader chooses the agency. No agency pays for placement in the Surrogacy4All rankings. Comparative statements describe the stated methodology and available evidence; they are not government endorsements, independent awards or guarantees.
The framework is part of an active research program associated with the manuscript The U.S. Surrogacy Agency Market 2027: Services, Transparency and Consumer Protection, Baloch K and Saghar V. The data table and rubric are available on request. Missing data are labeled unverified rather than treated as zero.
Send documented corrections to rankings@surrogacy4all.com.
Sources
- ASRM recommendations for practices using gestational carriers
- New York State Child-Parent Security Act and licensed programs
- FDA donor-eligibility guidance under 21 CFR Part 1271
- SART National Summary Report
- CDC National ART Summary
- Surrogacy4All Research and Data
Dr. Pooja Patel
Dr. Pooja Patel is a Manager of Surrogacy program at Surrogacy4all. She has 10 years of experience in Anesthesiology and critical care medicine.
She received her medical degree from Seth GS Medical College and K.E.M Hospital in India. She then completed an internship. She finished her Anesthesia residency at Grant Govt Medical College and JJ Group of Hospitals in India.
- Dr. Pooja Patel
- Dr. Pooja Patel
- Dr. Pooja Patel
- Dr. Pooja Patel
